Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Daniel Umbricht, MD
JCP
Original Research
Decoglurant for MDD Treatment
July 14, 2020
Read study discussing the treatment of MDD through modulation of dysregulated glutamate neurotransmission.
Daniel Umbricht
,
Markus Niggli
,
Patricia Sanwald-Ducray
, et al
JCP
Original Research
Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison
May 25, 2016
Nina R. Schooler
,
Stephen R. Marder
,
K. N. R. Chengappa
, et al
JCP
Original Research
The Prevalence of Acute Extrapyramidal Signs and Symptoms in Patients Treated With Clozapine, Risperidone, and Conventional Antipsychotics
February 15, 1998
Carl H. Miller
,
Fritz Mohr
,
Daniel Umbricht
, et al
